Pre-Clinical (Discovery and Development)
Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.
Unlocking AI's Transformative Potential in Life Sciences
November 07 by Joanna EdwardsExploring data integrity, collaboration, ethical standards, and the path forward for responsible AI adoption in pharma and healthcare.
Strengthening Cybersecurity in the Pharmaceutical Industry
October 31 by Joanna EdwardsDiscover how the pharmaceutical industry can protect sensitive data amid digital transformation.
Transforming Healthcare Communications: The Role of AI and Human Interaction at Cymphony
October 10 by Joanna EdwardsDiscover how AI can transform healthcare communications to deliver efficiencies and personalised patient care.
How Enterprise Architecture is Reshaping Modern Medicine
October 10 by Joanna EdwardsDiscover how Enterprise Architecture is transforming healthcare operations, enhancing patient care, and addressing technical debt in the industry.
AI in Pharma and Life Sciences: Balancing Innovation with Integrity
September 24 by Joanna EdwardsExplore how optimism and ethical concerns shape AI adoption in the Pharma & Healthcare industries in Elsevier's 2024 market report.
Exploring AI's Untapped Potential in Personalised Medicine
September 18 by Joanna EdwardsDiscover how AI is transforming personalised medicine and patient-specific treatments and how data integration can revolutionise drug discovery and healthcare.
AI's Role in Unveiling the True Value of Health Data
August 30 by Joanna EdwardsUnderstand the potential of AI to unlock the comprehensive value of health data and transform the healthcare sector.
Breaking New Ground: How AI and Protein Patterns Are Changing Disease Prediction
August 14 by Joanna EdwardsDiscover how AI and protein pattern analysis are transforming disease prediction. Latest research from Optima Partners, Biogen, and the University of Edinburgh.
Otsuka and Oxford HIN Collaborate on Digital Therapeutic for Major Depressive Disorder
August 14 by Joanna EdwardsDiscover how Otsuka and Oxford HIN are collaborating to evaluate and implement CARE for MDD, a digital therapeutic designed to treat major depressive disorder.
Revolutionising Drug Discovery: The Impact of AI and Patient-on-Chip Technology
August 09 by Joanna EdwardsDiscover how AI and patient-on-chip technology are revolutionising drug discovery and development.
The Connected Health Revolution: Transforming the Life Sciences Industry
August 01 by Joanna EdwardsExplore the transformative impact of connected health technologies in the life sciences industry, with key findings from Capgemini's report.
Navigating AI Integration in Pharma's Legacy Systems
July 31 by Joanna EdwardsExplore the challenges and strategic solutions involved in integrating AI into established legacy systems in the Pharma Industry.